Solventum Corp reported $14.16B in Interest Expense on Debt for its fiscal quarter ending in September of 2026.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
Align Technology USD 9.96M 3.02M Jun/2026
Baxter International USD 64M 14M Jun/2026
Becton, Dickinson and Co. USD 130M 2M Sep/2026
Cencora USD 154.52M 182K Jun/2026
Dexcom USD 3.1M 100K Sep/2026
Insulet USD 12.3M 1.3M Sep/2026
Solventum Corp USD 14.16B 78M Sep/2026
West Pharmaceutical Services USD 3.8M 1.2M Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026